MTD Group is proud to announce that it has successfully completed its first sustainability assessment with EcoVadis, a globally recognized platform for evaluating companies’ environmental,
Milan, August 2nd, 2024 – Medical Technology and Devices (MTD) is pleased to announce the successful closing of the acquisition of Ypsomed’s Pen Needles and
The MTD Group is pleased to announce that it has joined the United Nations Global Compact initiative, one of the world’s largest corporate sustainability programs,
Milan, 27 March 2024 – MTD (Medical Technology and Devices), a leading provider of medical technology solutions for self-care and professional use worldwide, announces the
2023 – Needlestick injuries (NSIs) may potentially expose healthcare professionals (HCPs) to bloodborne pathogens. Safety needles are designed to protect against NSIs. We evaluated whether
The MTD Group is proud to announce that its “G34 pen needle” device for insulin injection has received the highest award in the #LifeScienceExcellenceAwards 2022
MTD Group – a global leader in medical devices– today announced the FDA clearance obtained by its affiliate Pikdare S.p.A. for DropSafeTM SicuraTM passive safety
Lugano, 20th September 2022 – Medical Technology and Devices appointed Charles Bouaziz as new Chief Executive Officer of the Group. Charles is an industry veteran
MTD Exchange is a grassroots community program born with the objective to bring leaders, healthcare professionals and various stakeholders together to discuss and share experience
Lugano, 21st May 2021 – In delivering the COVID-19 global vaccination campaign, it is of paramount importance to be able to maximize the number of
